GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
11 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
10 Sep 2025 03:30 PM
RNS
Director/PDMR Shareholding
10 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
09 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
08 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
05 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
04 Sep 2025 03:30 PM
RNS
Director/PDMR Shareholding
04 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
03 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
02 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
01 Sep 2025 03:00 PM
RNS
Total Voting Rights
01 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
29 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
28 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
27 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
26 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
22 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
21 Aug 2025 03:30 PM
RNS
Director/PDMR Shareholding
21 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
20 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
19 Aug 2025 03:30 PM
RNS
Director/PDMR Shareholding
19 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
18 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
15 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
14 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
13 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
12 Aug 2025 03:30 PM
RNS
Director/PDMR Shareholding
12 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
11 Aug 2025 07:00 AM
RNS
FDA to review gonorrhea indication for gepotidacin
11 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
08 Aug 2025 07:00 AM
RNS
CureVac/BioNTech mRNA patent litigation settlement
08 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
07 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
06 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
05 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
04 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
01 Aug 2025 03:00 PM
RNS
Total Voting Rights
01 Aug 2025 07:00 AM
RNS
Transaction in Own Shares
31 Jul 2025 07:00 AM
RNS
Transaction in Own Shares
30 Jul 2025 07:05 AM
RNS
Transaction in Own Shares
30 Jul 2025 07:00 AM
RNS
2nd Quarter Results
29 Jul 2025 07:00 AM
RNS
Transaction in Own Shares
28 Jul 2025 07:00 AM
RNS
GSK enters Hengrui Pharma collaboration agreements
28 Jul 2025 07:00 AM
RNS
Transaction in Own Shares
25 Jul 2025 07:00 AM
RNS
Transaction in Own Shares
24 Jul 2025 05:00 PM
RNS
Blenrep approved in the EU for multiple myeloma
24 Jul 2025 07:00 AM
RNS
Transaction in Own Shares
23 Jul 2025 05:00 PM
RNS
US FDA review extended for Blenrep
23 Jul 2025 07:00 AM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings